Type IIB von Willebrand disease: A paradox explains how von Willebrand factor works

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 1, 2004, Pages 2-6

  Ruggeri, Zaverio M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Adhesion; Aggregation; Glycoprotein Ib; Platelets; Shear stress

Indexed keywords

CELL ADHESION MOLECULE; GLYCOPROTEIN IB; POLYCLONAL ANTIBODY; RISTOCETIN; THROMBOCYTE RECEPTOR; VON WILLEBRAND FACTOR;

ARTICLE; BLEEDING TENDENCY; HOMEOSTASIS; HUMAN; IMMUNOASSAY; IMMUNOELECTROPHORESIS; LABORATORY DIAGNOSIS; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOGENESIS; THROMBOSIS; VON WILLEBRAND DISEASE; BLOOD; GENETIC VARIABILITY; GENETICS; HISTORY; LITERATURE; PHYSIOLOGY;

AUTOBIOGRAPHY; HISTORY, 20TH CENTURY; HUMANS; VARIATION (GENETICS); VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 4444278190     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2003.00523.x     Document Type: Article

References (31)

1. Nichols WC, Cooney KA, Ginsburg D, Ruggeri ZM. von Willebrand disease. In: Loscalzo J, Schafer AI, eds. Thrombosis and Hemorrhage 3rd edn. Philadelphia: Lippincott, Williams & Wilkins, 2003: 539-59.
2. Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
3. Ginsburg D, Sadler JE. von Willebrand disease: a database of point mutations, insertions and deletions. Thromb Haemost 1993; 69: 177-84.
4. Ruggeri ZM, Zimmerman TS. von Willebrand factor and von Willebrand disease. Blood 1987; 70: 895-904.
5. Barbui T, Baudo F, Ciavarella N, Mariani G, Capitanio A, Mannucci PM, Pareti FI, Ruggeri ZM (Italian Working Group). Spectrum of von Willebrand's disease: a study of 100 cases. Br J Haematol 1977; 35: 101-12.
6. Howard MA, Firkin BG. Ristocetin - a new tool in the investigation of platelet aggregation. Thromb Haemost 1971; 26 362-9.
7. Howard MA, Sawers RJ, Firkin BG. Ristocetin. A means of differentiating von Willebrand's disease into two groups. Blood 1973; 41: 687-90.
8. Weiss HJ, Hoyer LW, Rickles FR, Varma N, Rogers J. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. J Clin Invest 1973; 52: 2708-16.
9. Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma J, Vicic WJ, Rogers J. Pseudo von Willebrand's disease: an intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high molecular weight multimers. N Engl J Med 1982; 306: 326-33.
10. Miller JL, Castella A. Platelet-type von Willebrand's disease: characterization of a new bleeding disorder. Blood 1982; 60: 790-3.
11. Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52.
12. van Mourik JA, Mochtar IA. Purification of human anti-hemophilic factor (factor VIII) by gel chromatography. Biochim Biophys Acta 1970; 221: 677-9.
13. Zimmerman TS, Ratnoff OD, Powell AE. Immunologic differentiation of classic hemophilia (Factor VIII deficiency) and von Willebrand's disease. With observations on combined deficiencies of antihemophilic factor and proaccelerin (Factor V) and on an acquired circulating anticoagulant against antihemophilic factor. J Clin Invest 1971; 50: 244-54.
14. Holmberg L, Nilsson IM. Two genetic variants of von Willebrand's disease. N Engl J Med 1973; 288: 595.
15. Ruggeri ZM, Pareti FI, Mannucci PM, Ciavarella N, Zimmerman TS. Heightened interaction between platelets and Factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease. N Engl J Med 1980; 302: 1047-51.
16. Ruggeri ZM, Zimmerman TS. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets. J Clin Invest 1980; 65: 1318-25.
17. Ruggeri ZM, Zimmerman TS. The complex multimeric composition of Factor VIII/von Willebrand factor. Blood 1981; 57: 1140-3.
18. Hoyer LW, Shainoff JR. Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers. Blood 1980; 55: 1056-9.
19. van Mourik JA, Bouma BN, La Bruyere WT, de Graaf S, Mochtar IA. Factor VIII, a series of homologous oligomers and a complex of two proteins. Thromb Res 1974; 4: 155-64.
20. Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells: identification of a large precursor polypeptide chain. J Biol Chem 1983; 258: 2065-7.
21. Ruggeri ZM, Mannucci PM, Federici AB, Lombardi R, Zimmerman TS. Multimeric composition of Factor VIII/von Willebrand factor following administration of DDAVP. Implications for pathophysiology and therapy of von Willebrand's disease subtypes. Blood 1982; 59: 1272-8.
22. Holmberg L, Nilsson IM, Borge L, Gunnarsson M, Sjorin E. Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease. N Engl J Med 1983; 309: 816-21.
23. Siediecki CA, Lestini BJ, Kottke-Marchant K, Eppell SJ, Wilson DL, Marchant RE. Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. Blood 1996; 88: 2939-50.
24. Savage B, Saldivar E, Ruggeri ZM. Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 1996; 84: 289-97.
25. Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 657-66.
26. Celikel R, Ruggeri ZM, Varughese KI. von Willebrand factor conformation and adhesive function is modulated by an internalized water molecule. Nature Structural Biol 2000; 7: 881-4.
27. Miura S, Li CQ, Cao Z, Wang H, Wardell MR, Sadler JE. Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion. J Biol Chem 2000; 275: 7539-46.
28. De Marco L, Girolami A, Zimmerman TS, Ruggeri ZM. Interaction of purified IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. Proc Natl Acad Sci USA 1985; 82: 7424-8.
29. De Marco L, Mazzucato M, Del Ben MG, Budde U, Federici AB, Girolami A, Ruggeri ZM. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. J Clin Invest 1987; 80: 475-82.
30. Budde U, Scharf RE, Franke P, Hartmann-Budde K, Dent J, Ruggeri ZM. Elevated platelet count as a cause of abnormal von Willebrand factor multimer distribution in plasma. Blood 1993; 82: 1749-57.
31. Huizinga EG, Tsuji S, Romijn RAP, Schiphorst ME, de Groot PG, Sixma JJ, Gros P. Structures of glycoprotein Ibα and its complex with von Willebrand factor A1 domain. Science 2002; 297: 1176-29.